Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Page 1
Effects of a Concentric Rare-Earth Magnet on Menstrual Cycle Pain: A Parallel Group Randomized Pilot Study.
Mayrovitz H, Milo B, Alexander B, Mastropasqua M, Moparthi Y. Mayrovitz H, et al. Among authors: mastropasqua m. Cureus. 2021 Jan 20;13(1):e12801. doi: 10.7759/cureus.12801. Cureus. 2021. PMID: 33628670 Free PMC article.
Percentage reduction in pain score was 41.8% 31.1% for magnet-treated vs. 20.8% 16.1%, for sham-treated (p<0.05). Conclusions Results suggest that short-term wearing of the magnet herein investigated, produces a meaningful menstrual-pain reduction in some women. ...
Percentage reduction in pain score was 41.8% 31.1% for magnet-treated vs. 20.8% 16.1%, for sham-treated (p<0.05). Conclusions Results sug …
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma.
Tamma R, Annese T, Ruggieri S, Brunetti O, Longo V, Cascardi E, Mastropasqua MG, Maiorano E, Silvestris N, Ribatti D. Tamma R, et al. Among authors: mastropasqua mg. Eur J Clin Invest. 2019 May;49(5):e13087. doi: 10.1111/eci.13087. Epub 2019 Mar 3. Eur J Clin Invest. 2019. PMID: 30767196
Inflammatory cells in tumour microenvironment support tumour growth in term of progression, angiogenesis and metastatic capacity. A link between inflammation and biliary carcinogenesis has been previously observed but the mechanisms involved remain to be determined. ...
Inflammatory cells in tumour microenvironment support tumour growth in term of progression, angiogenesis and metastatic capacity. A l …
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Disease-free survival at 10 years was 76.8% (95% CI 72.5-81.0) in the no axillary dissection group, compared with 74.9% (70.5-79.3) in the axillary dissection group (HR 0.85, 95% CI 0.65-1.11; log-rank p=0.24; p=0.0024 for non-inferiority). Long-term surgical complications …
Disease-free survival at 10 years was 76.8% (95% CI 72.5-81.0) in the no axillary dissection group, compared with 74.9% (70.5-79.3) in the a …
DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).
Galimberti V, Monti S, Mastropasqua MG. Galimberti V, et al. Among authors: mastropasqua mg. Breast. 2013 Aug;22(4):431-5. doi: 10.1016/j.breast.2013.04.010. Epub 2013 May 3. Breast. 2013. PMID: 23643807
DCIS--now considered medium-high grade DIN). Elimination of the term 'carcinoma' from entities that cannot metastasize will reduce confusion among health professionals and patients, and contribute to reducing the risk of overtreatment, as well as reducing adverse psycholog …
DCIS--now considered medium-high grade DIN). Elimination of the term 'carcinoma' from entities that cannot metastasize will reduce co …
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Among authors: mastropasqua mg. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Other non-breast cancer events were recorded in 21 patients in the axillary dissection group and eight in the no axillary dissection group (20 and six second non-breast malignancies; and one and two deaths not due to a cancer event). 5-year disease-free survival was 87.8% (95% CI …
Other non-breast cancer events were recorded in 21 patients in the axillary dissection group and eight in the no axillary dissection group ( …
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG). Regan MM, et al. Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20. Lancet Oncol. 2011. PMID: 22018631 Free PMC article. Clinical Trial.
BACKGROUND: Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extended follow-up. ...
BACKGROUND: Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer …
[Malaria: recent immunological acquisitions and therapeutic prospects].
Leri O, Perinelli P, Losi T, Mastropasqua M, Peri C, Tubili S. Leri O, et al. Among authors: mastropasqua m. Clin Ter. 1997 Dec;148(12):655-65. Clin Ter. 1997. PMID: 9528202 Review. Italian.
A malaria vaccine aimed at disrupting the parasites life cycle at one or more of the three stages (sporozoite or pre-erythrocytic stage, asexual blood or erythrocytic stage, and sexual or sporogonic stage) might be a long-term solution....
A malaria vaccine aimed at disrupting the parasites life cycle at one or more of the three stages (sporozoite or pre-erythrocytic stage, ase …